majority of recent cancer drugs approved for use in uk show no survival benefits study finds

The majority of cancer drugs approved for use in the UK in recent years are not proven to extend life, research has found. The study published in the BMJ examined 48 medications approved by the European Medicines Agency (EMA) to treat 68 separate cancers from 2009 to 2013. It found that in two thirds of...